Wei Wen
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Inflammatory Biomarkers in Disease Prognosis
Papers in
-
- RNA modifications and cancer 2
- Oncology 6
- Cancer Cells and Metastasis 2
- Co-authors
- Ying Zhu (1 shared paper)Xiaoli Zhang (1 shared paper)Xiuqin Zhang (2 shared papers)Rui‐Ping Xiao (2 shared papers)Kui Liu (1 shared paper)Ye Yuan (2 shared papers)Miao Xu (1 shared paper)Wei Hu (1 shared paper)
- Journals
- Frontiers in Oncology (2 papers)Biochemical and Biophysical Research Communications (1 paper)Journal of the American College of Surgeons (1 paper)International Immunopharmacology (1 paper)Cancer Biomarkers (1 paper)
- Partner nations
- ChinaPhilippinesUnited States
In The Last Decade
Wei Wen
21 papers receiving 357 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 97
- Oncology 78
- Hepatology 22
- Molecular Biology 154
- Genetics 19
Countries citing papers authored by Wei Wen
This map shows the geographic impact of Wei Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wen more than expected).
Fields of papers citing papers by Wei Wen
This network shows the impact of papers produced by Wei Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wen. The network helps show where Wei Wen may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Wen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 71 | |
| 2 | 2010 | 49 | |
| 3 | 2019 | 42 | |
| 4 | 2017 | 27 | |
| 5 | 2022 | 26 | |
| 6 | 2017 | 22 | |
| 7 | 2019 | 20 | |
| 8 | Estimating the costs of esophageal cancer screening, early diagnosis and treatment in three high risk areas in China. | 2011 | 20 |
| 9 | 2016 | 17 | |
| 10 | 2024 | 14 | |
| 11 | 2022 | 11 | |
| 12 | 2022 | 9 | |
| 13 | 2016 | 8 | |
| 14 | 2022 | 7 | |
| 15 | 2023 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2017 | 3 | |
| 18 | 2011 | 3 | |
| 19 | 2025 | 1 | |
| 20 | [The affect of Si-Rac1b on the malignant biological behaviors of colorectal cancer cell]. | 2011 | 1 |
About Wei Wen
Wei Wen is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Genetics, having authored 25 papers that have together received 359 indexed citations. Recurring topics across this work include Liver physiology and pathology (2 papers), Cancer Cells and Metastasis (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), Esophageal Cancer Research and Treatment (2 papers), Cancer Research and Treatments (2 papers), Mesenchymal stem cell research (2 papers), Gastric Cancer Management and Outcomes (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (97 citations), Oncology (78 citations), Hepatology (22 citations), Molecular Biology (154 citations) and Genetics (19 citations). Wei Wen has collaborated with scholars based in China, Philippines and United States. Frequent co-authors include Ying Zhu, Xiaoli Zhang, Xiuqin Zhang, Rui‐Ping Xiao, Kui Liu, Ye Yuan, Miao Xu, Wei Hu, Yi Zhao and Peiqing Zhao. Their work appears in journals such as Frontiers in Oncology, Biochemical and Biophysical Research Communications, Journal of the American College of Surgeons, International Immunopharmacology and Cancer Biomarkers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.